Yes, the business model is easily replicated, but look at the brand names they have attracted since start up, and they are aggresively seeking more big names
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025